ÂÜÀòÂÒÂ×

Justin Eyquem has a long and varied work experience. Justin started in 2008 as an intern at Cellectis. In 2009, they were an intern at the Institut Jacques Monod/CNRS - Membrane Dynamics and Regulations Group, as well as the University of Amsterdam - Synthetic Biology Group (Photanol). In 2010, they became a PhD student at Cellectis Therapeutics, where they were responsible for engineering T lymphocytes to improve antitumor activity, cell engraftment and proliferation. In 2014, they became a Postdoctoral Research Fellow at MSKCC. In 2019, they became an Assistant Professor and Principal Investigator - Parker Fellow at the University of California, San Francisco. In 2020, they became a Co-Founder at Mnemo Therapeutics.

Justin Eyquem received their Doctor of Philosophy (PhD) in Genome Editing and Adoptive Immunotherapy from Universit\u00e9 Paris Cit\u00e9 between 2010 and 2014. Justin also obtained a Master in Genetics from Universit\u00e9 Paris Diderot - Paris VII in 2009-2010. Prior to that, Justin Eyquem completed their Ing\u00e9nieur degree from AgroParisTech between 2006 and 2010.